Evidence map›Paper›PMID 40211364›Full record

ArticleJournal of orthopaedic surgery and research2025

The efficacy of oxidised regenerated cellulose powder in reducing blood loss during primary total hip arthroplasty: a retrospective cohort study.

Pil Whan Yoon, Hong Jin Kim, Jae Youn Yoon, Jun-Ki Moon, Sunhyung Lee

Abstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Effectiveness and Safety of Oxidized Regenerated Cellulose for Hemostasis in Joint Arthroplasty: A Systematic Review and Meta-Analysis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Pooled it
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pil Whan Yoon *Department of Orthopaedic Surgery, Seoul Now Hospital, Anyang, Gyeonggi, South Korea.ORCID http://orcid.org/0000-0001-7354-0989
Hong Jin Kim *Department of Orthopaedic Surgery, Kyung-in Regional Military Manpower Administration, Suwon, South Korea.ORCID http://orcid.org/0000-0002-8162-9585
Jae Youn YoonDepartment of Orthopaedic Surgery, Seoul Now Hospital, Anyang, Gyeonggi, South Korea.ORCID http://orcid.org/0000-0003-4449-7314
Jun-Ki Moon *Department of Orthopaedic Surgery, Chung-Ang Top Orthopaedic Clinic, Seoul, South Korea. junkimoon85@gmail.com.ORCID http://orcid.org/0000-0003-2983-3922
Sunhyung Lee *Department of Orthopaedic Surgery, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea.ORCID http://orcid.org/0000-0003-2814-6346

Funding

Johnson & Johnson MedTech, Korea 0000000037
6 · The paper itself

Abstract

backgroundOxidised regenerative cellulose (ORC) is an absorbable haemostatic agent that acts independently on the blood coagulation mechanisms. Although ORC products have been used as adjuncts in various surgical procedures, their haemostatic effect, particularly the powder type (Surgicel

methodsThis study included 279 patients who underwent primary THA between January 2022 and July 2024, and they were divided into two groups based on the use of ORC powder: the control (n = 138) and SC (SurgiCel group, n = 141) groups. Data on perioperative outcomes, including operative time, total blood loss (TBL), intraoperative blood loss (IBL), hidden blood loss (HBL), haemoglobin (Hb) drops, and complication rates over 3 months, were collected and compared between the two groups.

resultsThe mean IBL was significantly lower in the SC group (197.1 mL) than in the control group (243.5 mL) (P < 0.001). The total operative time (P = 0.465), procedure time (P = 0.117), TBL (P = 0.167), and HBL (P = 0.771) showed no significant differences. The mean postoperative Hb drop was significantly different between the control and SC groups (1.5 vs. 1.0 g/dL, P < 0.001). Similarly, the mean postoperative day 1 Hb drop was significantly lower in the SC group than in the control group (1.7 vs. 2.0 g/dL, P = 0.013). Complication rates showed no significant differences during the 3-month postoperative follow-up.

conclusionsORC powder significantly reduced IBL and postoperative Hb drops without any comparable complications in patients undergoing primary THA. These findings suggest that ORC powder is a safe and effective haemostatic agent during primary THA procedures, which may be a valuable adjuvant for reducing blood loss and potential to reduce blood transfusion requirements.

Indexed as

Arthroplasty, Replacement, HipBlood Loss, SurgicalCelluloseCellulose, OxidizedHemostaticsAgedCohort StudiesFemaleHumansMaleMiddle AgedOperative TimePowdersRetrospective StudiesTreatment OutcomeCelluloseCellulose, OxidizedHemostaticsPowdersSurgicelBlood lossHaemoglobin dropHaemostatic effectOxidised regenerative celluloseTotal hip arthroplasty

Identifiers

PMID40211364
PMCPMC11987413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.